CERVICAL CANCER VACCINE

Motion Text

That this House congratulates the Imperial Cancer Research Fund, Cancer Research Campaign and the Ludwig Institute for backing the development of a vaccine against the human papilloma virus to protect women against cervical cancer that affects 4,000 women and causes 1,600 deaths every year; supports the clinical trials in Manchester and thanks the 30 volunteers and scientists involved in the trials; and hopes that a vaccine will be available to women within the next 10 years.